These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35268667)

  • 1. In Vitro and Computational Studies of Perezone and Perezone Angelate as Potential Anti-Glioblastoma Multiforme Agents.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Martínez J; Macías Pérez ME; Rosales Cruz E; Żołek T; Maciejewska D; Miranda Ruvalcaba R; Mera Jiménez E; Nicolás-Vázquez MI
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and computational studies showed that perezone inhibits PARP-1 and induces changes in the redox state of K562 cells.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Macias Perez ME; Rosales Cruz E; Mera Jiménez E; Nicolás Vázquez MI; Miranda Ruvalcaba R
    Arch Biochem Biophys; 2019 Aug; 671():225-234. PubMed ID: 31063714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and computational studies of natural products related to perezone as anti-neoplastic agents.
    Hernández-Rodríguez M; Mendoza Sánchez PI; Macías Perez ME; Cruz ER; Jiménez EM; Aceves-Hernández JM; Nicolás-Vázquez MI; Ruvalcaba RM
    Biochimie; 2020; 171-172():158-169. PubMed ID: 32145350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Two New Sulfur Derivatives of Perezone: In Silico Study Simulation Targeting PARP-1 and In Vitro Study Validation Using Cancer Cell Lines.
    Rubiales-Martínez A; Martínez J; Mera-Jiménez E; Pérez-Flores J; Téllez-Isaías G; Miranda Ruvalcaba R; Hernández-Rodríguez M; Mancilla Percino T; Macías Pérez ME; Nicolás-Vázquez MI
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model.
    Hwang JY; Park JH; Kim MJ; Kim WJ; Ha KT; Choi BT; Lee SY; Shin HK
    Cancer Lett; 2019 Feb; 443():25-33. PubMed ID: 30503550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP-1 protein expression in glioblastoma multiforme.
    Galia A; Calogero AE; Condorelli R; Fraggetta F; La Corte A; Ridolfo F; Bosco P; Castiglione R; Salemi M
    Eur J Histochem; 2012 Feb; 56(1):e9. PubMed ID: 22472897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perezone and its phenyl glycine derivative induce cytotoxicity via caspases on human glial cancer cells.
    Estévez-Carmona MM; Ramírez-Apan MT; Zaragoza-Ojeda M; Vega-Miranda A; Arenas-Huertero F; Reynolds WF; Obregón-Mendoza MA
    Nat Prod Res; 2024 Jun; 38(11):1823-1833. PubMed ID: 37341748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained inhibition of PARP-1 activity delays glioblastoma recurrence by enhancing radiation-induced senescence.
    Ghorai A; Mahaddalkar T; Thorat R; Dutt S
    Cancer Lett; 2020 Oct; 490():44-53. PubMed ID: 32645394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
    Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
    PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising anti- cervical carcinoma and inflammatory agent, Resveratrol targets poly (ADP-ribose) polymerase 1 (PARP-1) induced premature ovarian failure with a potent enzymatic modulatory activity.
    Alharbi H; Alshehri AS; Ahmad M; Guo WW
    J Reprod Immunol; 2021 Apr; 144():103272. PubMed ID: 33465522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma.
    Rasmussen RD; Gajjar MK; Jensen KE; Hamerlik P
    Mol Oncol; 2016 May; 10(5):751-63. PubMed ID: 26794465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts.
    Gupta SK; Mladek AC; Carlson BL; Boakye-Agyeman F; Bakken KK; Kizilbash SH; Schroeder MA; Reid J; Sarkaria JN
    Clin Cancer Res; 2014 Jul; 20(14):3730-41. PubMed ID: 24838527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
    Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
    Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines.
    Sucu BO; Koc EB; Savlug Ipek O; Mirat A; Almas F; Guzel MA; Dogan B; Uludag D; Karakas N; Durdagi S; Guzel M
    J Mol Graph Model; 2022 Jun; 113():108160. PubMed ID: 35248814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.
    Tentori L; Ricci-Vitiani L; Muzi A; Ciccarone F; Pelacchi F; Calabrese R; Runci D; Pallini R; Caiafa P; Graziani G
    BMC Cancer; 2014 Mar; 14():151. PubMed ID: 24593254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
    Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
    Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
    Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
    J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma.
    Wu S; Li X; Gao F; de Groot JF; Koul D; Yung WKA
    Neuro Oncol; 2021 Jun; 23(6):920-931. PubMed ID: 33433610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).
    Li J; Tang H; Zhang Y; Tang C; Li B; Wang Y; Gao Z; Luo P; Yin A; Wang X; Cheng G; Fei Z
    PLoS One; 2013; 8(11):e81258. PubMed ID: 24278406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.